GlassScriptPhysician profile
John Joseph Schier
NPI 1932440054
$1,633.64
in general payments reported to CMS, 2019-2025
7 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.64 · 2020: $177 · 2021: $809 · 2022: $213 · 2023: $123 · 2024: $116 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279 · Education: $78.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.33 |
| Education | $78.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $962.78 | 2019-2024 | |
| Kls-Martin L.P. | $436.39 | 2020-2025 | |
| Colgate Oral Pharmaceuticals, INC. | $78.66 | 2024 | |
| Keystone Dental INC. | $55.22 | 2021 | |
| Nobel Biocare USA | $45.65 | 2019 | |
| Geistlich Pharma, North America, INC. | $36.43 | 2020-2021 | |
| Depuy Synthes Sales INC. | $18.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.